Gerlich W
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2022; 65(2):170-182.
PMID: 35015108
PMC: 8751463.
DOI: 10.1007/s00103-021-03484-w.
Cid R, Bolivar J
Biomolecules. 2021; 11(8).
PMID: 34439738
PMC: 8394948.
DOI: 10.3390/biom11081072.
Moradi Vahdat M, Hemmati F, Ghorbani A, Rutkowska D, Afsharifar A, Eskandari M
Biotechnol Rep (Amst). 2021; 29:e00605.
PMID: 33732633
PMC: 7937989.
DOI: 10.1016/j.btre.2021.e00605.
Wang C, Tsai H
World J Gastroenterol. 2021; 27(1):19-36.
PMID: 33505148
PMC: 7789062.
DOI: 10.3748/wjg.v27.i1.19.
Khuroo M, Sofi A
J Clin Exp Hepatol. 2020; 10(4):391-401.
PMID: 32655240
PMC: 7335725.
DOI: 10.1016/j.jceh.2020.04.006.
Hepatitis B vaccine development and implementation.
Zhao H, Zhou X, Zhou Y
Hum Vaccin Immunother. 2020; 16(7):1533-1544.
PMID: 32186974
PMC: 7482909.
DOI: 10.1080/21645515.2020.1732166.
Comparative purification and characterization of hepatitis B virus-like particles produced by recombinant vaccinia viruses in human hepatoma cells and human primary hepatocytes.
Reuschel E, Jilg W, Seelbach-Goebel B, Deml L
PLoS One. 2019; 14(2):e0212800.
PMID: 30794666
PMC: 6386438.
DOI: 10.1371/journal.pone.0212800.
Effects of mRNA secondary structure on the expression of HEV ORF2 proteins in Escherichia coli.
Behloul N, Wei W, Baha S, Liu Z, Wen J, Meng J
Microb Cell Fact. 2017; 16(1):200.
PMID: 29137642
PMC: 5686824.
DOI: 10.1186/s12934-017-0812-8.
Biotechnology and the transformation of vaccine innovation: The case of the hepatitis B vaccines 1968-2000.
Huzair F, Sturdy S
Stud Hist Philos Biol Biomed Sci. 2017; 64:11-21.
PMID: 28511068
PMC: 5541201.
DOI: 10.1016/j.shpsc.2017.05.004.
Engineering hepatitis B virus core particles for targeting HER2 receptors in vitro and in vivo.
Bin Mohamed Suffian I, Wang J, Hodgins N, Klippstein R, Garcia-Maya M, Brown P
Biomaterials. 2017; 120:126-138.
PMID: 28056402
PMC: 5300899.
DOI: 10.1016/j.biomaterials.2016.12.012.
Vaccine technologies: From whole organisms to rationally designed protein assemblies.
Karch C, Burkhard P
Biochem Pharmacol. 2016; 120:1-14.
PMID: 27157411
PMC: 5079805.
DOI: 10.1016/j.bcp.2016.05.001.
Prophylactic vaccination against hepatitis B: achievements, challenges and perspectives.
Gerlich W
Med Microbiol Immunol. 2014; 204(1):39-55.
PMID: 25523195
DOI: 10.1007/s00430-014-0373-y.
Phage display creates innovative applications to combat hepatitis B virus.
Tan W, Ho K
World J Gastroenterol. 2014; 20(33):11650-70.
PMID: 25206271
PMC: 4155357.
DOI: 10.3748/wjg.v20.i33.11650.
Construction and characterization of virus-like particles: a review.
Zeltins A
Mol Biotechnol. 2012; 53(1):92-107.
PMID: 23001867
PMC: 7090963.
DOI: 10.1007/s12033-012-9598-4.
Viral nanoparticles as macromolecular devices for new therapeutic and pharmaceutical approaches.
Grasso S, Santi L
Int J Physiol Pathophysiol Pharmacol. 2011; 2(2):161-178.
PMID: 21383892
PMC: 3047266.
Crystallization and X-ray analysis of the T = 4 particle of hepatitis B capsid protein with an N-terminal extension.
Tan W, McNae I, Ho K, Walkinshaw M
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2007; 63(Pt 8):642-7.
PMID: 17671358
PMC: 2335152.
DOI: 10.1107/S1744309107033726.
Isolation and Mapping of Small Cauliflower Mosaic Virus DNA Fragments Active as Promoters in Escherichia coli.
McKnight T, Meagher R
J Virol. 1981; 37(2):673-82.
PMID: 16789206
PMC: 171055.
DOI: 10.1128/JVI.37.2.673-682.1981.
Hepatitis B virus proteins expressed by recombinant vaccinia viruses: influence of preS2 sequence on expression surface and nucleocapsid proteins in human diploid cells.
Kutinova L, Nemeckova S, Hamsikova E, Zavadova H, Ludvikova V, Broucek J
Arch Virol. 1994; 134(1-2):1-15.
PMID: 8279947
DOI: 10.1007/BF01379102.
A eukaryotic cytosolic chaperonin is associated with a high molecular weight intermediate in the assembly of hepatitis B virus capsid, a multimeric particle.
Lingappa J, Martin R, Wong M, Ganem D, Welch W, Lingappa V
J Cell Biol. 1994; 125(1):99-111.
PMID: 7908022
PMC: 2120005.
DOI: 10.1083/jcb.125.1.99.
Selection of peptide inhibitors of interactions involved in complex protein assemblies: association of the core and surface antigens of hepatitis B virus.
Dyson M, Murray K
Proc Natl Acad Sci U S A. 1995; 92(6):2194-8.
PMID: 7892246
PMC: 42450.
DOI: 10.1073/pnas.92.6.2194.